The latest biotech news

seasonal influenza universal vaccine sanofi peptcell seek niaid nihr

News and Trends 12 Nov 2015

Sanofi’s COBRA Research to Tackle the Challenge of A Universal Influenza Vaccine for Winter

Sanofi Pasteur is the infectious disease division of the French Giant Sanofi, responsible for producing 1 Billion vaccine doses each year. Now they are looking to ‘evolve’ the vaccine R&D field, adapting their approach to find a broader spectrum defense against seasonal Influenza strains. However, the UK NIHR and PepTCell are also after the same […]

November 12, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 12 Nov 2015

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

I am still at the mRNA Convention in Berlin…and was invited for a second interview – this time with the ‘RNA People’, battling to be the first to get an mRNA Drug onto the Worldwide Market. I had a chat with Franz-Werner Haas, the Chief Corporate Office of CureVac. We talked a lot about this […]

November 12, 2015 - 1 minutemin - By Philip Hemme

News and Trends 12 Nov 2015

EU’s Largest Private Biotech talking on the Future of mRNA Therapies

Today is the 3rd International mRNA Health Conference in Berlin. I jumped in the metro to go there and interview the most successful people of the field… We first interviewed Sean Marett, COO of BioNTech. This German Biotech is the largest private Biotech in EU and so far counts over 400 employees…BioNTech also recently signed […]

November 12, 2015 - 1 minutemin - By Philip Hemme

News and Trends 12 Nov 2015

The Dermatology People in Denmark are Buying Out Japanese Skin Blockbusters

Leo Pharma has entered an Asset Purchasing Agreement of €675M for the Japanese Derma business of Astellas in Tokyo, to include their products for eczema, acne and their dermatitis blockbuster Protopic. Leo Pharma, which is headquartered in Copenhagen (Denmark), has therapeutic areas beyond the cosmetic, with other areas of research including skin cancer (melanoma) and […]

November 12, 2015 - 2 minutesmins - By Dani Bancroft

diatoms neuroblastoma chemotherapy algae TUdresden biocube

News and Trends 11 Nov 2015

Using Algae and NanoTech to Kill Cancer: An Australian-German Collaboration

Algae diatoms are now being used to kill cancer! A new research paper on nano-particles from Adelaide (Australia) has worked with researchers at the Dresden University of Technology (TUD) to create an algae-encapsulated chemotherapy, as published in Nature. This is certainly exciting stuff. Diatoms are a type of microalgae that have a silica based ‘shell’, […]

November 11, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 11 Nov 2015

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers. Now their phase I clinical trial of belinostat (trade name Beleodaq) combined with chemo for relapses in non-Hodgkin Lymphomas has shown an 89% response rate. Originally developed by TopoTarget (a biotech in Copenhagen) Belinostat is now under Onxeo’s portfolio (along […]

November 11, 2015 - 3 minutesmins - By Dani Bancroft

nightstarx oxford chroideremia night blindness

News and Trends 11 Nov 2015

Oxford’s Nightstar Gene Therapy for Blindness in Men Shines with $35M Fundraiser

Choroideremia is a rare X-linked recessive retinal disease which eventually leads to blindness. A series B funding round has landed the NightstaRx (‘Nightstar’) biotech in Oxford an additional $35M for their vision-improving gene therapy. Since the mutation causing Choroideremia is sex-linked, sufferers are almost always males, with the onset of symptoms in childhood often starting […]

November 11, 2015 - 3 minutesmins - By Dani Bancroft

dani bancroft copenhaganen fugt algae transart fest

News and Trends 10 Nov 2015

What the FUGT? We tried the Algae Bar Beer for the TransArt Fest in Copenhagen!

We went to the TransArt Festival at the stunning ‘Dome of Visions‘ in Copenhagen on Friday. There, we met loads of scientists and members of the public who were just as entranced as us by the home-grown BioArt. After our blogger Julie covered the Fab Foundation’s ‘Biohacking’ movement last Monday, I was really intrigued by […]

November 10, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 10 Nov 2015

The 10 Hottest Bioincubators in Europe

A Bioincubator is a launch-pad structure for entrepreneurs to make their project in the sciences real. In Europe, we have many incubators within each industry, responsible for strategic investment, development and providing a support network for start-ups. Bioincubators are considered as the first ‘home’ for young biotech companies, providing entrepreneurs access to research laboratories, technology platforms, specific […]

November 10, 2015 - 5 minutesmins - By Nicolas Sainte-Foie

News and Trends 9 Nov 2015

A Group of French Medics are Questioning the Fastest-Growing Big Biotech in the World…

Approved drugs can always show bad signs once injected massively. Four physicians from Paris sent a letter to the New England Journal of Medicine to report that Gilead’s Hepatitis C blockbuster drug, Sovaldi, can cause abnormally slower heart rates and risks of Heart Failure… The French Physicians report used data based on 415 patients treated […]

November 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 9 Nov 2015

This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve

Human insulin produced in Bacteria is already a miracle for Diabetes…but sometimes, it’s not as efficient as it could be. The French Biotech Adocia is developing a super-insulin and showed successful efficiency data in a early-stage human trials. Adocia is a Lyon-based Biotech we have discussed before. Even if its logo is a bit strange […]

November 9, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 9 Nov 2015

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford’s Adaptimmune has some surprisingly good results too. Adaptimmune is a British, Oxford-based immuno-oncolgy company. It held a massive IPO last year, raising up to €150M on the NASDAQ, and its CEO was interviewed by BIO (video here) where he seemed […]

November 9, 2015 - 2 minutesmins - By Philip Hemme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Sanofi’s COBRA Research to Tackle the Challenge of A Universal Influenza Vaccine for Winter

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

EU’s Largest Private Biotech talking on the Future of mRNA Therapies

The Dermatology People in Denmark are Buying Out Japanese Skin Blockbusters

Using Algae and NanoTech to Kill Cancer: An Australian-German Collaboration

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

Oxford’s Nightstar Gene Therapy for Blindness in Men Shines with $35M Fundraiser

What the FUGT? We tried the Algae Bar Beer for the TransArt Fest in Copenhagen!

The 10 Hottest Bioincubators in Europe

A Group of French Medics are Questioning the Fastest-Growing Big Biotech in the World…

This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Subscribe to our newsletter to get the latest biotech news!